| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adenosine A2A receptor antagonists in Parkinson's disease: still in the running
|
Antonini, Angelo
|
|
2014
|
13 |
8 |
p. 748-749
2 p.
|
article
|
| 2 |
Capitalising on modifiable risk factors for Alzheimer's disease
|
Biessels, Geert Jan
|
|
2014
|
13 |
8 |
p. 752-753
2 p.
|
article
|
| 3 |
Corrections
|
|
|
2014
|
13 |
8 |
p. 757-
1 p.
|
article
|
| 4 |
Corrections
|
|
|
2014
|
13 |
8 |
p. 757-
1 p.
|
article
|
| 5 |
David Gutmann: making science work for patients
|
Thorn, Sheila M
|
|
2014
|
13 |
8 |
p. 762-
1 p.
|
article
|
| 6 |
Development of new treatments for Batten disease
|
Mole, Sara E
|
|
2014
|
13 |
8 |
p. 749-751
3 p.
|
article
|
| 7 |
Does neurology need a faster FDA?
|
Burton, Adrian
|
|
2014
|
13 |
8 |
p. 760-761
2 p.
|
article
|
| 8 |
Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study
|
Brickshawana, Adipong
|
|
2014
|
13 |
8 |
p. 795-806
12 p.
|
article
|
| 9 |
KIR4.1: another misleading expectation in multiple sclerosis?
|
Filippi, Massimo
|
|
2014
|
13 |
8 |
p. 753-755
3 p.
|
article
|
| 10 |
Learning about the brain with comics
|
Cantor, Abi
|
|
2014
|
13 |
8 |
p. 764-
1 p.
|
article
|
| 11 |
Measures and outcomes
|
Goodrick, Steven
|
|
2014
|
13 |
8 |
p. 763-
1 p.
|
article
|
| 12 |
Neurofibromatosis type 1: a multidisciplinary approach to care
|
Hirbe, Angela C
|
|
2014
|
13 |
8 |
p. 834-843
10 p.
|
article
|
| 13 |
Neuro Film Festival: How do we make someone understand us?
|
Morgan, Jules
|
|
2014
|
13 |
8 |
p. 765-
1 p.
|
article
|
| 14 |
News in brief
|
|
|
2014
|
13 |
8 |
p. 766-
1 p.
|
article
|
| 15 |
Oral cysteamine bitartrate and N-acetylcysteine for patients with infantile neuronal ceroid lipofuscinosis: a pilot study
|
Levin, Sondra W
|
|
2014
|
13 |
8 |
p. 777-787
11 p.
|
article
|
| 16 |
Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging
|
Ciccarelli, Olga
|
|
2014
|
13 |
8 |
p. 807-822
16 p.
|
article
|
| 17 |
Potential for primary prevention of Alzheimer's disease: an analysis of population-based data
|
Norton, Sam
|
|
2014
|
13 |
8 |
p. 788-794
7 p.
|
article
|
| 18 |
Stroke and cerebrovascular diseases in patients with chronic kidney disease
|
Toyoda, Kazunori
|
|
2014
|
13 |
8 |
p. 823-833
11 p.
|
article
|
| 19 |
Tackling the sports-related concussion crisis
|
The Lancet Neurology,
|
|
2014
|
13 |
8 |
p. 747-
1 p.
|
article
|
| 20 |
The Glasgow Coma Scale at 40 years: standing the test of time
|
Teasdale, Graham
|
|
2014
|
13 |
8 |
p. 844-854
11 p.
|
article
|
| 21 |
The Glasgow Coma Scale: time for critical reappraisal?
|
Laureys, Steven
|
|
2014
|
13 |
8 |
p. 755-757
3 p.
|
article
|
| 22 |
Todd Hardy
|
|
|
2014
|
13 |
8 |
p. 763-
1 p.
|
article
|
| 23 |
Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial
|
Hauser, Robert A
|
|
2014
|
13 |
8 |
p. 767-776
10 p.
|
article
|
| 24 |
Urate and neuroprotection trials
|
Schwarzschild, Michael A
|
|
2014
|
13 |
8 |
p. 758-
1 p.
|
article
|
| 25 |
Urate and neuroprotection trials – Authors' reply
|
Chamorro, Ángel
|
|
2014
|
13 |
8 |
p. 758-759
2 p.
|
article
|
Journal description